WestEnd Advisors’s Zimmer Biomet ZBH Stock Holding History

WestEnd Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$543	Hold	6	–	–	﹤0.01%	303
2025 Q4	$540	Hold	6	–	–	﹤0.01%	303
2025 Q3	$591	Sell	6 -3	-33%	-$297	﹤0.01%	290
2025 Q2	$821	Buy	9 +2	+29%	+$193	﹤0.01%	227
2025 Q1	$792	Buy	7 +4	+133%	+$428	﹤0.01%	230
2024 Q4	$317	Buy	3 +1	+50%	+$107	﹤0.01%	218
2024 Q3	$216	Sell	2 -1	-33%	-$109	﹤0.01%	285
2024 Q2	$326	Hold	3	–	–	﹤0.01%	199
2024 Q1	$396	Hold	3	–	–	﹤0.01%	174
2023 Q4	$365	Hold	3	–	–	﹤0.01%	180
2023 Q3	$337	Buy	+3	New	+$381	﹤0.01%	185
2023 Q1	–	Sell	-2	Closed	-$251	–	173
2022 Q4	$255	Sell	2 -1	-33%	-$116	﹤0.01%	201
2022 Q3	$0	Hold	3	–	–	﹤0.01%	341
2022 Q2	$315	Buy	+3	New	+$356	﹤0.01%	167
2022 Q1	–	Sell	-2	Closed	-$241	–	204
2021 Q4	$254	Buy	+2	New	+$262	﹤0.01%	232
2021 Q3	–	Hold	0	–	–	–	202
2021 Q2	–	Hold	0	–	–	–	191

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WestEnd Advisors's ZBH Position: Q1 2026 in Review

WestEnd Advisors held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 6 shares worth $543. The position accounts for ﹤0.01% of the portfolio, ranked #303.

WestEnd Advisors first reported a position in ZBH in Q4 2021 and has held it in 15 quarters since. The position peaked at $821 in Q2 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

WestEnd Advisors held 6 shares of Zimmer Biomet worth $543 as of Q1 2026.
WestEnd Advisors left its Zimmer Biomet share count unchanged in Q1 2026.
Zimmer Biomet made up ﹤0.01% of WestEnd Advisors's portfolio in Q1 2026, its #303 holding.
WestEnd Advisors first reported a position in Zimmer Biomet in Q4 2021 and has held it in 15 quarters since.
WestEnd Advisors's Zimmer Biomet position peaked at $821 in Q2 2025.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on WestEnd Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.